Warfarin and Genetic Variations
Back to Search Results
March 2010
Thomas Moyer, Ph.D., from Mayo Clinic's Department of Laboratory Medicine and Pathology, offers background on the blood-thinner warfarin and why genetic variations in patients affect the dose that will be needed to prevent both blood clots and possible side effects, such as excessive bleeding.
External
link
PDF
document
Excel
document
Word
document